HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andre Terzic Selected Research

Adenylate Kinase

1/2020Adenylate Kinase and Metabolic Signaling in Cancer Cells.
4/2009Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.
10/2007Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow.
1/2004Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy.
8/2002Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andre Terzic Research Topics

Disease

39Heart Failure
01/2021 - 04/2003
10Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2020 - 04/2004
9Neoplasms (Cancer)
01/2022 - 07/2002
9Cardiomyopathies (Cardiomyopathy)
01/2020 - 06/2008
8Heart Diseases (Heart Disease)
11/2017 - 12/2006
8Channelopathies
08/2011 - 04/2003
7Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 03/2006
7Ischemia
08/2008 - 08/2002
6Infarction (Infarctions)
01/2020 - 05/2005
5Osteonecrosis (Kienbock's Disease)
11/2021 - 04/2016
5Myocardial Infarction
08/2011 - 08/2004
5Hypoxia (Hypoxemia)
10/2007 - 07/2003
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 08/2008
4Teratoma (Teratoid Tumor)
05/2016 - 10/2008
4Cardiac Arrhythmias (Arrythmia)
06/2015 - 10/2002
4Obesity
12/2010 - 04/2009
3Disease Susceptibility (Diathesis)
01/2022 - 12/2009
3Cardiomegaly (Heart Hypertrophy)
01/2020 - 10/2008
3Hypertrophy
05/2011 - 12/2006
3Hypertension (High Blood Pressure)
05/2011 - 08/2006
3Atrial Fibrillation
07/2010 - 07/2006
2Wounds and Injuries (Trauma)
01/2021 - 05/2016
2Arteriovenous Fistula
11/2018 - 10/2011
2Cardiac Sudden Death (Sudden Cardiac Arrest)
03/2017 - 08/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2016 - 01/2013
2Muscular Diseases (Myopathy)
01/2016 - 10/2004
2MELAS Syndrome (Syndrome, MELAS)
08/2015 - 07/2013
2Fibrosis (Cirrhosis)
03/2015 - 05/2011
2Infections
02/2015 - 06/2007
2Cicatrix (Scar)
08/2014 - 09/2013
2Sudden Death
07/2014 - 10/2002
2Mitochondrial Diseases (Mitochondrial Disease)
07/2013 - 10/2007
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
04/2009 - 10/2004
1Breast Neoplasms (Breast Cancer)
01/2022
1Renal Insufficiency (Renal Failure)
08/2020
1Hereditary renal agenesis
08/2020
1Pneumoperitoneum
06/2020
1Lymphedema (Milroy Disease)
04/2020
1Paralysis (Palsy)
01/2020
1Meningomyelocele (Myelomeningocele)
01/2020
1Spinal Injuries (Spinal Injury)
01/2020
1Spinal Cord Injuries (Spinal Cord Injury)
01/2020
1Ventricular Remodeling
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Patent Ductus Arteriosus
12/2019
1Chronic Disease (Chronic Diseases)
11/2019
1Pain (Aches)
01/2018
1Congenital Diaphragmatic Hernias
01/2018
1Teratocarcinoma
05/2016
1Vitamin D Deficiency
01/2016
1Muscle Weakness
01/2016
1Chronic Kidney Failure (Chronic Renal Failure)
01/2016
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
01/2016

Drug/Important Bio-Agent (IBA)

28Adenosine Triphosphate (ATP)IBA
01/2022 - 04/2003
8ProteomeIBA
01/2022 - 03/2009
7Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
7KATP ChannelsIBA
07/2010 - 04/2004
6CalciumIBA
12/2006 - 07/2002
5Adenylate KinaseIBA
01/2020 - 08/2002
5salicylhydroxamic acid (SHAM)IBA
11/2017 - 08/2004
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021 - 04/2016
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2022 - 01/2004
3Protein Isoforms (Isoforms)IBA
01/2022 - 04/2009
3Etoposide (VP 16)FDA LinkGeneric
01/2020 - 10/2012
3DNA (Deoxyribonucleic Acid)IBA
10/2014 - 04/2004
3Adrenergic Agents (Adrenergic Drugs)IBA
07/2010 - 08/2004
3Biomarkers (Surrogate Marker)IBA
12/2009 - 05/2007
3MicroRNAs (MicroRNA)IBA
06/2009 - 05/2007
3Diazoxide (Hyperstat)FDA Link
10/2007 - 07/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 04/2011
2Adenosine Monophosphate (AMP)IBA
01/2020 - 04/2009
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2019 - 06/2015
2Mitochondrial DNA (mtDNA)IBA
08/2015 - 07/2013
2NucleotidesIBA
08/2015 - 04/2003
2PotassiumIBA
08/2010 - 08/2006
2Adenosine Diphosphate (ADP)IBA
08/2008 - 01/2004
2ElementsIBA
11/2006 - 08/2006
2Adenosine Triphosphatases (ATPase)IBA
01/2004 - 04/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2003 - 04/2003
1IsotopesIBA
01/2022
1HexokinaseIBA
01/2022
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2021
14-isothiocyanatobenzyl-desferrioxamineIBA
11/2020
1ZirconiumIBA
11/2020
1tetraethylpyrazine (TEP)IBA
06/2020
1tetra-4-amidinophenoxypropane (TAPP)IBA
06/2020
1CollagenIBA
05/2016
1GelsIBA
05/2016
1hydroxide ionIBA
01/2016

Therapy/Procedure

40Therapeutics
01/2021 - 08/2004
9Transplantation
11/2020 - 10/2008
5Cell- and Tissue-Based Therapy (Cell Therapy)
10/2020 - 10/2010
4Cardiac Resynchronization Therapy
06/2015 - 09/2013
2Decompression
11/2021 - 01/2018
2Precision Medicine
01/2018 - 12/2009
2Catheters
02/2016 - 06/2003
1Injections
12/2020
1Length of Stay
04/2020
1Arthroplasty
01/2018
1Biological Therapy
03/2017